Skip to main content
Clinical Trials/KCT0004198
KCT0004198Not yet recruiting未知

Feasibility study of interval compressed regimen using four-drugs for osteosarcoma

ational Cancer Center0 sites53 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor
Enrollment
53

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional Study

Eligibility Criteria

Ages
5(Year) to 39(Year) (—)
Sex
All

Inclusion Criteria

  • newly diagnosed osteosarcoma patients aged 5 to 50 years
  • *control group: aged 19 to 40 years, who denied acute or chronic disease, 15 patients with each gender

Exclusion Criteria

  • patients with impaired organ function
  • patients who cannot meet the criteria below
  • -renal function: CCr or GFR or eGFR = 70 mL/min/1.73 m2, liver function: AST/ALT = 5 x upper limit, total bilirubin = 1.5 x upper limit of normal for age, heart function : shortening fraction = 24% or ejection fraction = 50% (Echo), lung function: no respiratory compromise, SaO2 =95% at room air, bone marrow: ANC = 750/uL and platelet = 75,000/uL
  • patients who do not agree this protocol
  • pregnant or lactating woman
  • hypersensitivity to drugs in this study
  • patients who received prior chemotherapy

Investigators

Sponsor
ational Cancer Center

Similar Trials